This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AngioDynamics Management Discusses Q4 2012 Results - Earnings Call Transcript

AngioDynamics (ANGO)

Q4 2012 Earnings Call

July 12, 2012 4:30 pm ET


Bob Jones

Joseph M. DeVivo - Chief Executive Officer, President and Director

D. Joseph Gersuk - Chief Financial Officer, Chief Accounting Officer, Executive Vice President and Treasurer


Jayson T. Bedford - Raymond James & Associates, Inc., Research Division

Brooks E. West - Piper Jaffray Companies, Research Division

Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division

Charles Croson - Sidoti & Company, LLC

Jason R. Mills - Canaccord Genuity, Research Division

Robert M. Goldman - CL King & Associates, Inc.

Larry Haimovitch - Haimovitch Medical Technology Consultants



Good day, ladies and gentlemen, and thank you for standing by. Welcome to the AngioDynamics Fourth Quarter 2012 Earnings Conference Call. [Operator Instructions] This conference is being recorded today, July 12, 2012. I would now like to turn the conference over to Mr. Bob Jones. Please go ahead.

Bob Jones

Thank you, operator, and welcome to the AngioDynamics conference call to review the results of the fiscal 2012 fourth quarter and full year ended May 31, 2012.

As Joe DeVivo has just had mentioned, we have sent the news release to the wire services and is in process of being distributed. But in the interest of time, we didn't want to begin the call. This call is being broadcast live with accompanying presentation -- slide presentation, which are now available on the AngioDynamics' website. A replay of the call will also be archived on the company's website. To access both the live webcast and the archived replay, including the presentation slides, please go to the Investors section under Events and Presentations. If you are listening by telephone, to view the slide presentation, navigate to the live webcast as noted and choose the no audio slides only option to view the slides in conjunction with the live conference call.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.77 -0.50%
FB $118.62 0.69%
GOOG $707.00 0.79%
TSLA $212.79 0.60%
YHOO $36.87 -0.19%


Chart of I:DJI
DOW 17,649.96 -10.75 -0.06%
S&P 500 2,042.68 -7.95 -0.39%
NASDAQ 4,692.03 -25.0640 -0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs